alantolactone has been researched along with Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Kuang, JX; Li, YW; Liu, X; Miao, CX; Shen, Q; Zhang, WL; Zhang, XW | 1 |
| Larrosa, I; Osborne, HC; Schmidt, CK | 1 |
| Babaei, G; Gholizadeh-Ghaleh Aziz, S; Khadem Ansari, MH; Rajabi Bazl, M | 1 |
| Ali, M; Khan, M; Li, J; Li, X; Rasul, A | 1 |
3 review(s) available for alantolactone and Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
A comprehensive review of anticancer mechanisms of action of Alantolactone.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Movement; Humans; Lactones; Neoplasm Metastasis; Neoplasms; Oxidative Stress; Reactive Oxygen Species; Sesquiterpenes, Eudesmane; Signal Transduction | 2021 |
Targeting apoptosis pathways in cancer with alantolactone and isoalantolactone.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Humans; Lactones; Neoplasm Proteins; Neoplasms; Sesquiterpenes; Sesquiterpenes, Eudesmane | 2013 |
2 other study(ies) available for alantolactone and Neoplasms
| Article | Year |
|---|---|
Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway.
Topics: Animals; Cachexia; Humans; Lactones; Mice; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Atrophy; Neoplasms; Sesquiterpenes, Eudesmane; Signal Transduction; STAT3 Transcription Factor | 2022 |
Sesquiterpene Lactones Potentiate Olaparib-Induced DNA Damage in p53 Wildtype Cancer Cells.
Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromosomal Instability; Dose-Response Relationship, Drug; Drug Synergism; Humans; Lactones; Neoplasms; Oxidative Stress; Phthalazines; Piperazines; Pyrazoles; Pyrimidinones; Sesquiterpenes; Sesquiterpenes, Eudesmane; Tumor Suppressor Protein p53 | 2022 |